Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Libre“
Suchtreffer
Begriffe & Kennungen
Cocktail, Cuba Libre
Eintrag öffnenMulibrey-Zwergwuchs
Eintrag öffnenRetsevmo · 4.8 · 15 Tabulated list of adverse drug reactions in LIBRETTO-121
Eintrag öffnenRetsevmo · 4.8 · 17 (37.5%), than in patients <65 years of age (7.6%). In study LIBRETTO-431, the frequency of AE leading to di
Eintrag öffnenRetsevmo · 4.8 · 48 In LIBRETTO-001, the median time to onset was 1.9 weeks (range: 0.7 to 203.9 weeks): 1.7 weeks in patients
Eintrag öffnenRetsevmo · 4.8 · Hypertension In the 837 patients who had blood pressure measurements in study LIBRETTO-001, the median maximum
Eintrag öffnenRetsevmo · 4.8 · Hypertension In the 837 patients who had blood pressure measurements in study LIBRETTO-001, the median maximum
Eintrag öffnenRetsevmo · 4.8 · In LIBRETTO-001, LIBRETTO-431 and LIBRETTO-531 studies, there were no reports of torsades de pointes, events o
Eintrag öffnenRetsevmo · 4.8 · In LIBRETTO-001, LIBRETTO-431 and LIBRETTO-531 studies, there were no reports of torsades de pointes, events o
Eintrag öffnenRetsevmo · 4.8 · Median time on treatment with selpercatinib was 30.09 months (Study LIBRETTO-001), 16.7 months (Study LIBRETTO
Eintrag öffnenRetsevmo · 4.8 · Median time on treatment with selpercatinib was 30.09 months (Study LIBRETTO-001), 16.7 months (Study LIBRETTO
Eintrag öffnenRetsevmo · 4.8 · Paediatric patients There were 3 patients < 18 years (range: 15-17) of age with RET-mutant MTC in LIBRETTO-001
Eintrag öffnenRetsevmo · 4.8 · Paediatric patients There were 3 patients < 18 years (range: 15-17) of age with RET-mutant MTC in LIBRETTO-001
Eintrag öffnenRetsevmo · 4.8 · QT interval prolongation In the 837 patients in study LIBRETTO-001 who had ECGs, review of data showed 8.1% of
Eintrag öffnenRetsevmo · 4.8 · QT interval prolongation In the 837 patients in study LIBRETTO-001 who had ECGs, review of data showed 8.1% of
Eintrag öffnenRetsevmo · 4.8 · Table 6 Adverse drug reactions in patients receiving selpercatinib in Study LIBRETTO- 121 (n=36)
Eintrag öffnenRetsevmo · 4.8 · Table 6 Adverse drug reactions in patients receiving selpercatinib in Study LIBRETTO- 121 (n=36)
Eintrag öffnenRetsevmo · 4.8 · Tabulated list of adverse drug reactions in LIBRETTO-121
Eintrag öffnenRetsevmo · 4.8 · The integrated frequency and severity of ADRs reported in patients treated with selpercatinib in Study LIBRETT
Eintrag öffnenRetsevmo · 4.8 · The integrated frequency and severity of ADRs reported in patients treated with selpercatinib in Study LIBRETT
Eintrag öffnen